Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2012
07/03/2012CA2388818C C-aryl glucoside sglt2 inhibitors and method
07/03/2012CA2370805C Ureas as cell adhesion modulators
06/2012
06/28/2012WO2012086735A1 Condensed heterocyclic compound
06/28/2012WO2012086406A1 Glp-1 secretagogue
06/28/2012WO2012086241A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
06/28/2012WO2012086184A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/28/2012WO2012084999A1 Prokineticin 1 receptor agonists and their uses
06/28/2012WO2012084928A1 Radioiodinated guanidines
06/28/2012WO2012084459A1 Prevention and therapy methods for preterm deliveries and births
06/28/2012WO2012083396A1 Method for increasing embryo implantation rate in mother's uterus in mammals, use of an effective amount of beta - galactoside - binding lectin or derivatives thereof, beta - galactoside - binding lectin or derivatives and product.
06/28/2012US20120165401 Aptamer for chymase, and use thereof
06/28/2012US20120165400 Gene repair involving in vivo excision of targeting dna
06/28/2012US20120165396 Modulation of exportin 5 expression
06/28/2012US20120165387 General composition framework for ligand-controlled RNA regulatory systems
06/28/2012US20120165363 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
06/28/2012US20120165359 Opioid Agonist/Antagonist Combinations
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF
06/28/2012US20120165265 Calcium Signaling Modulators Involving STIM and ORAI Proteins
06/28/2012US20120164223 Rapidly disintegrating, solid coated dosage form
06/28/2012US20120164190 Nanoparticle isoflavone compositions & methods of making and using the same
06/28/2012US20120164183 Method for detection and treatment of aneurysms
06/28/2012US20120164147 Mammalian genes; related reagents and methods
06/28/2012US20120164118 Cocal vesiculovirus envelope pseudotyped retroviral vectors
06/28/2012US20120164112 Expanding hematopoietic stem cells
06/28/2012US20120164108 Virus strains
06/28/2012US20120164070 Benzothiazole and benzooxazole derivatives and methods of use
06/28/2012CA2822758A1 Optically active diazabicyclooctane derivative and process for preparing the same
06/28/2012CA2817688A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/27/2012EP2468865A1 Antisense oligonucleotide modulation of stat3 expression
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468729A1 Novel indazole derivative
06/27/2012EP2468281A1 Quinoline derivative-containing pharmaceutical composition
06/27/2012EP2468279A1 Prokineticin 1 receptor agonists and their uses
06/27/2012EP2468273A2 Method to reduce oxidative damage and improve mitochondrial efficiency
06/27/2012EP2468266A2 Pharmaceutical compositions for acute glucocorticoid therapy
06/27/2012EP2468094A1 Composition and methods for modulation of vascular structure and/or function
06/27/2012EP2467128A1 Use of glyceryl trinitrate for treating traumatic edema
06/27/2012EP2202216B1 Spiro-ring compound and use thereof for medical purposes
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012CN1972688B 4-phenylamino-quinazolin-6-yl-amides
06/27/2012CN1678304B PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
06/27/2012CN102516384A MLKL protein and application of MLKL protein as target point of cell necrosis inhibitor
06/27/2012CN102516364A Active peptide for simulating porcine growth hormone-like effect, preparation method for active peptide and application of active peptide
06/27/2012CN102516170A Amide derivatives
06/27/2012CN102516150A Crystalline forms of fluvastatin sodium
06/27/2012CN102512631A Chinese medicinal composition for treating jaundice
06/27/2012CN102512612A Tonic cream for myna to practice voice
06/27/2012CN102512585A Traditional Chinese medicine used for treating yin deficiency and fire hyperactivity
06/27/2012CN102512529A Traditional Chinese medicinal patch for treating infantile night cry
06/27/2012CN102511673A Coenzyme Q10 premix and its preparation method and use
06/27/2012CN102178866B Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof
06/27/2012CN102078493B Preparation method and application of compound astragalus root preparation
06/27/2012CN102008622B Traditional Chinese medicine for treating atrophy
06/27/2012CN101967123B 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof
06/27/2012CN101836976B Application of icaritin in preparation of anti-angiogenic medicaments
06/27/2012CN101808668B Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101559114B Application of traditional Chinese medicine composition in preparing antihypoxic
06/27/2012CN101535280B Arylsulfonamide compounds
06/27/2012CN101479288B Improved treatment of cystic fibrosis
06/27/2012CN101333196B 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/27/2012CN101156680B Food composition of nourishing blood anti-senescence and method for producing same
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207230 Functional role for cannabinoids in autonomic stability during sleep
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8207142 Inhibitor of DNA methylation
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207119 Ophthalmological composition
06/26/2012US8206965 Single-chain rare-cutting endonucleases; for genetic engineering and gene therapy
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206704 Use of GCC ligands
06/26/2012US8206699 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2554493C Bicycloester derivative
06/26/2012CA2445875C Pentapeptide compounds and uses related thereto
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/26/2012CA2426952C Small molecule compositions for binding to hsp90
06/26/2012CA2406853C Methods and compositions for eliciting an immune response
06/21/2012WO2012081736A1 Continuous arycyclic compound
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081665A1 Substance capable of inhibiting glycine transporter
06/21/2012WO2012081570A1 Lactam compound or a salt thereof, and ppar activator
06/21/2012WO2012081563A1 Benzothiazole and azabenzothiazole derivative having endothelial lipase inhibitory activity
06/21/2012WO2012080273A1 N- acetyl - l - cysteine for treatment of polycystic ovary syndrome
06/21/2012US20120157547 Compositions and applications of carotenoids of improved absorption and bioavailability
06/21/2012US20120157481 Tricyclic pyrimidine derivatives as wnt antagonists
06/21/2012US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
06/21/2012US20120156306 Viral inactivated platelet extract, use and preparation thereof
06/21/2012US20120156265 Conformable tissue repair implant capable of injection delivery
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012CA2821900A1 Continuous arycyclic compound
06/21/2012CA2821893A1 Pyrazole derivative
06/20/2012EP2465856A2 Cytochrome P450 oxidase inhibitors and uses thereof
06/20/2012EP2465855A1 Cytochrome P450 oxidase inhibitors and uses thereof
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 1564